Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Bluebird-Bio
Company Monitoring Page for Bluebird-Bio
latest headlines for company on cafepharma
ASH18: New data can’t lift Bluebird Bio’s depressed shares
Fierce Biotech
Tue, 12/4/18 - 10:02 am
Tags:
Bluebird Bio
,
ASH 2018
ASH18: Bluebird's follow-on CAR-T finds initial success, but durability will be key test
Biopharma Dive
Sun, 12/2/18 - 10:50 pm
Tags:
ASH2018
,
Bluebird Bio
,
CAR-T
,
bb21217
Top Biotech Stocks to Watch at ASH 2018
Yahoo/Motley Fool
Sun, 12/2/18 - 12:37 pm
Tags:
ASH2018
,
Celgene
,
Bluebird Bio
,
Acceleron
Waiting for bluebird bio to Sing at ASH
Motley Fool
Sat, 11/10/18 - 12:05 pm
Tags:
Bluebird Bio
,
earnings
,
ASH
,
CAR-T
3 Cancer Stocks to Watch in December
Motley Fool
Wed, 11/7/18 - 10:06 am
Tags:
Acceleron
,
luspatercept
,
Bluebird Bio
,
bb21217
,
Amgen
,
AMG 420
Here's Why bluebird bio Dropped 13.3% in September
Motley Fool
Thu, 10/11/18 - 10:54 pm
Tags:
Bluebird Bio
,
Amgen
EMA Accepts Bluebird Bio's Marketing Authorization Application for Gene Therapy for Rare Blood Disorder
CP Wire
Fri, 10/5/18 - 09:50 am
Tags:
Bluebird Bio
,
transfusion-dependent anemia
,
LentiGlobin
,
EMA
,
Europe
Fri, 10/5/18 - 09:18 am
Tags:
Bluebird Bio
,
transfusion-dependent anemia
,
LentiGlobin
Why bluebird and Celgene Should Worry About Amgen's Latest Clinical Victory
Motley Fool
Fri, 09/14/18 - 11:59 pm
Tags:
Bluebird Bio
,
Amgen
,
Celgene
,
AMG-420
,
bb2121
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Mon, 09/3/18 - 01:09 pm
Tags:
Adamis
,
GSK
,
Sangamo BioSciences
,
Roche
,
Bluebird Bio
,
ProQR Therapeutics
,
Geron
,
Amarin
,
Palatin
,
EyeGate
,
Galactin
,
Omeros
,
Atossa Genetics
Bluebird taps Gritstone for oncology cell therapy targets
Fierce Biotech
Thu, 08/23/18 - 11:04 am
Tags:
Bluebird Bio
,
Gritstone Oncology
,
oncology
,
T-cell receptors
,
drug development
Express Scripts staking out million-dollar gene therapies
Reuters
Wed, 08/15/18 - 10:32 pm
Tags:
Express Scripts
,
PBMs
,
gene therapies
,
drug pricing
,
Biomarin
,
Bluebird Bio
,
Spark Therapeutics
Regeneron And Bluebird Team To Invent New Cell Therapies For Cancer
Forbes
Mon, 08/6/18 - 11:53 am
Tags:
Regeneron
,
Bluebird Bio
,
CAR-T
,
drug discovery
,
gene therapy
,
cancer
Bluebird’s first gene therapy gets European fast track
PM Live
Sat, 07/28/18 - 12:26 pm
Tags:
Bluebird Bio
,
gene therapy
,
EMA
,
LentiGlobin
Celgene tweaks trial of myeloma CAR-T bb2121, raising dose
Fierce Biotech
Fri, 07/13/18 - 09:44 am
Tags:
Celgene
,
clinical trials
,
bb2121
,
Bluebird Bio
,
Multiple Myeloma
,
CAR-T
Why bluebird bio's Shares Have Tumbled 11.9% in 2018 So Far
Motley Fool
Mon, 07/9/18 - 10:48 am
Tags:
Bluebird Bio
,
gene therapy
,
beta thalassemia
,
LentiGlobin
Evercore ISI Says Bluebird Bio Has Path To Commercialization, Madrigal Pharma Outpaced By Mid-Cap Alternatives
Yahoo/Benzinga
Sun, 06/24/18 - 09:32 pm
Tags:
Bluebird Bio
,
Celgene
,
LentiGlobin
,
Madrigal Pharmaceuticals
Demand For Gene Therapies To Prompt Surge In Pharma M&A
Forbes
Tue, 06/19/18 - 10:11 pm
Tags:
gene therapy
,
M&A
,
Bluebird Bio
,
Sangamo Therapeutics
Bluebird Bio Announces More Good News for LentiGlobin Gene Therapy – Exciting Results in Sickle Cell Disease
CP Wire
Fri, 06/15/18 - 10:02 am
Tags:
Bluebird Bio
,
sickle cell disease
,
LentiGlobin
,
gene therapy
Bluebird Bio Presents Promising Results for Gene Therapy in Rare Blood Disorder
CP Wire
Fri, 06/15/18 - 10:01 am
Tags:
Bluebird Bio
,
gene therapy
,
LentiGlobin
,
beta thalassemia
,
sickle cell disease
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.